2016 前列腺癌规范化标本取材及病理诊断共识

2016-10-15 中华医学会病理学分会 中华病理学杂志,2016,45(10): 676-680.

前列腺癌是一组发生于前列腺内的恶性上皮性肿瘤的统称,位居男性最常见恶性肿瘤的第二位,根据我国近年来的癌症统计数据,前列腺癌的发病率逐年递增。在前列腺癌的诊疗过程中,病理学诊断是前列腺癌确诊、治疗方案选择及患者预后评估的重要依据。

中文标题:

2016 前列腺癌规范化标本取材及病理诊断共识

发布日期:

2016-10-15

简要介绍:

前列腺癌是一组发生于前列腺内的恶性上皮性肿瘤的统称,位居男性最常见恶性肿瘤的第二位,根据我国近年来的癌症统计数据,前列腺癌的发病率逐年递增。在前列腺癌的诊疗过程中,病理学诊断是前列腺癌确诊、治疗方案选择及患者预后评估的重要依据。为此,中华医学会病理学分会泌尿男性生殖系统疾病学组(筹)参照2016年版WHO泌尿系统及男性生殖器官肿瘤分类、国际泌尿病理协会(International Society of Urological Pathology,ISUP)对根治性前列腺癌取材、前列腺腺癌Gleason分级标准等一系列共识内容,制定了规范化的前列腺癌取材及病理诊断共识(简称共识),内容包括前列腺标本送检及处理、取材方法、病理诊断、病理诊断报告书推荐格式等。该共识初稿首先经学组专家内部交流,然后在2016年3月经参加全国泌尿男性生殖病理学组学术研讨会的与会专家进一步深入交流,最终达成共识,旨在为提高我国前列腺癌病理诊断的规范化及标准化水平提供指导性建议。

制定者:

中华医学会病理学分会
泌尿男性生殖系统疾病病理专家组

拓展指南:前列腺癌相关指南:

下载附件:

(因为版权问题,不支持下载)

评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=223907, encodeId=9ce422390e71, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/24/c26e935092765e8bfbde89e5237eb939.jpg, createdBy=86882090647, createdName=Dr.孙, createdTime=Wed Jul 19 12:56:21 CST 2017, time=2017-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=150994, encodeId=eb09150994be, content=学习了,指导性文件, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160601/IMG574E13FEE55F33222.jpg, createdBy=929c1478678, createdName=zibozhouping, createdTime=Tue Oct 25 06:46:03 CST 2016, time=2016-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=150752, encodeId=ce16150e52bb, content=阅读了谢谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Mon Oct 24 07:43:41 CST 2016, time=2016-10-24, status=1, ipAttribution=)]
    2017-07-19 Dr.孙

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=223907, encodeId=9ce422390e71, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/24/c26e935092765e8bfbde89e5237eb939.jpg, createdBy=86882090647, createdName=Dr.孙, createdTime=Wed Jul 19 12:56:21 CST 2017, time=2017-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=150994, encodeId=eb09150994be, content=学习了,指导性文件, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160601/IMG574E13FEE55F33222.jpg, createdBy=929c1478678, createdName=zibozhouping, createdTime=Tue Oct 25 06:46:03 CST 2016, time=2016-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=150752, encodeId=ce16150e52bb, content=阅读了谢谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Mon Oct 24 07:43:41 CST 2016, time=2016-10-24, status=1, ipAttribution=)]
    2016-10-25 zibozhouping

    学习了,指导性文件

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=223907, encodeId=9ce422390e71, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/24/c26e935092765e8bfbde89e5237eb939.jpg, createdBy=86882090647, createdName=Dr.孙, createdTime=Wed Jul 19 12:56:21 CST 2017, time=2017-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=150994, encodeId=eb09150994be, content=学习了,指导性文件, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160601/IMG574E13FEE55F33222.jpg, createdBy=929c1478678, createdName=zibozhouping, createdTime=Tue Oct 25 06:46:03 CST 2016, time=2016-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=150752, encodeId=ce16150e52bb, content=阅读了谢谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Mon Oct 24 07:43:41 CST 2016, time=2016-10-24, status=1, ipAttribution=)]
    2016-10-24 刘煜

    阅读了谢谢分享。

    0